Not enough for South African mutation... "Customized Vaccine Boost"

<Anchor>

As previously mentioned, the AstraZeneca vaccine is expected to enter Korea and start vaccination this month.

However, the efficacy of this vaccine continues to be controversial.

When a study found that the effect was limited against the mutant virus from South Africa, the UK announced that it would update the vaccine and give it a third dose this fall.

This is reporter Kim Kyung-hee.

<Reporter> The

UK, the first in the world to be vaccinated against Corona 19, has announced that it will be vaccinated once more this fall in response to the mutant virus.

Although 12 million people have already completed the first dose, it is based on the judgment that it is not enough to stop the spread of the mutant virus.

In particular, the AstraZeneca vaccine is planned to be developed tailored to South African mutations according to the results of research that shows that the prevention effect of the South African mutation is significantly lower.

Earlier, the South African government withheld AstraZeneca vaccination, saying the effect on the South African mutation was limited.

But the British government stressed that it is time to get vaccinated without hesitation.

[Jonathan Van Tam/England Deputy Chief Medical Officer: Should I get this vaccine now?"

If you ask, my advice is simple.

Don't delay getting the vaccine and protect you from the current threats.]

Despite the controversy over efficacy, the AstraZeneca vaccine has been launched in France.

The Minister of Health said that the virus that spreads in France is not mutated in South Africa, so the AstraZeneca vaccine is sufficient.

Cobax Facility, an international project to jointly purchase vaccines, said it currently has no plans to reject the AstraZeneca vaccine.